NCT02285816 2026-03-09MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid TumoursCanadian Cancer Trials GroupPhase 1/2 Active not recruiting56 enrolled